单分散,大粒径聚苯乙烯微球的研制

制备可用于清除骨髓中癌细胞的磁性微球。以苯乙烯为单体，二乙烯苯为交联剂，采用二步溶胀法合成单分散，大粒径的聚苯乙烯高分子微球。合成了粒径为３．５７μｍ分散度为０．０７７的聚苯乙烯微球，并可方便地得到多孔和交联微球。活性溶胀乳剂乳滴的大小、丙酮的含量对活性溶胀效果有较显著的影响、活性溶胀乳剂的种类搅拌速度，单体加入量是影响微球性质的主要因素。     

单分散多孔St/DVB共聚微球的制备

用分散聚合法制出了粒径约为2μm的单分散聚苯乙烯(PSt)种子，再通过改进的活性二步种子溶胀法制得了粒径约为4．5μm的单分散多孔St／DVB共聚微球。在溶胀阶段，用XSP-8CA生物显微镜观察活化、溶胀温度，1～氯代十二烷(CD，mL)／PSt(g)的比例及单体混合物总体积对溶胀种子粒径及单分散的影响，确定了合适的制备工艺条件。用SEM观察多孔聚合物微球的粒径和形貌，并用BET法考察了不同比例的及甲苯浓度变化对多孔聚合物微球孔结构的影响，实验表明，随着VDVB／Vst的比例的增大和甲苯浓度的提高，多孔微球的比表面积增大，孔分布向小孔区域移动。     

磺化聚苯乙烯纳米微球-聚丙烯酰胺杂化水凝胶的制备及性能

首先通过乳液聚合法合成了聚苯乙烯（PS）微球,该微球经浓硫酸磺化后得到了磺化聚苯乙烯（SPS）微球;然后将合成的SPS微球作为多功能交联点加入丙稀酰胺（AAm）化学水凝胶网络中制备了SPS-PAAm杂化水凝胶。通过扫描电镜、透射电镜观察了SPS微球及杂化水凝胶的微观结构。研究了SPS微球对SPS-PAAm杂化水凝胶的凝胶分数、溶胀性能和力学性能的影响。结果显示：随着SPS微球用量的增加,SPS-PAAm水凝胶的凝胶分数先增加后降低,平衡溶胀度降低;SPS微球的加入能改善水凝胶的力学性能,随着SPS含量的增加,水凝胶的拉伸强度和能量损耗增加;SPS微球和PAAm分子链间存在物理相互作用。     

单分散聚苯乙烯微球的制备及影响因素研究

以聚乙烯吡咯烷酮为分散剂，无水乙醇为反应介质，偶氮二异丁腈为引发剂，采用分散聚合工艺，通过优化反应条件，制备出了粒径为5μm单分散（分散系数≤5％）聚苯乙烯微球。所制备的聚苯乙烯微球标准偏差δ＝0．16μm，分散系数ε＝0．02，且具有良好的球形度，表面非常光滑，无破损，无缺损。对影响单分散聚苯乙烯微球的因素进行了研究，结果表明：随着分散稳定剂用量的增加，聚苯乙烯微球的粒径减小；随着单体和引发剂用量的增加，聚苯乙烯微球的粒径增大。分散稳定剂和单体用量是影响聚苯乙烯微球粒径分布的两个主要因素。     

分散聚合法制备单分散交联聚苯乙烯微球

以苯乙烯为单体、二乙烯基苯为交联剂,通过优化反应条件,制备了平均粒径为3.28～9.04 μm的单分散聚苯乙烯微球和平均粒径为6.60 μm的单分散交联聚苯乙烯微球.探讨了单体浓度、引发剂含量、分散稳定剂用量对微球粒径和分散性的影响.热稳定性分析表明:交联聚苯乙烯微球耐热性明显优于线性聚苯乙烯.     

无皂乳液聚合法合成均一性聚苯乙烯微球

研究了聚苯乙烯微球的合成过程中，离子强度、聚合时间对粒径的影响及其稳定性，实验结果表明：适当改变离子强度、聚合时间可以得到不同粒径的聚苯乙烯微球，且粒子稳定性较好。     

两步后交联法制备氯甲基化聚苯乙烯交联微球

以平均粒径为40μm的非交联氯甲基化聚苯乙烯(CMPS)微球为出发物料,采用水解-轻度交联与重度交联两步骤的后交联方法,制备了氯甲基化聚苯乙烯交联微球.用红外光谱表征了交联前后微球化学结构的变化,使用扫描电镜观察了交联微球的形貌,重,点考察了各种交联条件对微球交联度的影响规律,分析了交联反应机理.结果表明:先将非交联氯甲基化聚苯乙烯微球部分水解并轻度交联,然后使CMPS微球在良溶剂中溶胀,使用Friedel-Crafts催化剂,再度进行交联反应,可顺利地制得氯甲基化聚苯乙烯(CCMPS)交联微球;控制交联反应的条件,如反应温度、反应时间、溶剂性质、催化剂种类与用量等,可获得交联度不同的微球,其球形度依然保持良好.     

种球溶胀法制备有机聚合物色谱填料及其在纯化红景天苷中的应用

采用分散聚合法,以正丁醇为介质制成单分散的聚苯乙烯微球,应用该微球通过种球溶胀法制备聚苯乙烯-二乙烯苯(PSt-DVB)色谱填料。应用高压匀质机制备的活化种球和溶胀活化种球的乳液更稳定,液滴更小。该填料单分散性能优越,填装4.6 mm×150 mm的色谱柱背压低,可用作分析色谱和制备色谱。该色谱柱用于红景天苷的分离,可获得98%以上的纯品。     

种子乳液聚合法制备中空多孔聚合物微球

用分散聚合法制得粒径约为3μm的聚苯乙烯种子微球，通过溶胀，种子乳液聚合及萃取得到中空多孔聚合微球，使用扫描电镜检测了其中空多孔形貌和粒径，并讨论了成孔机理。     

微米级PS-PEDOT核壳型导电微球的合成与拉曼表征

以分散聚合法制备的微米级聚苯乙烯(PS)微球为模板、3,4-乙烯二氧噻吩(EDOT)为单体、过硫酸铵(APS)为引发剂,通过氧化聚合制备了PS-PEDOT核壳型复合导电微球。采用扫描电镜、透射电镜等对导电微球的形貌和结构进行了表征,重点采用拉曼光谱研究了其核壳结构特征。并研究了超声分散、溶液pH以及单体配比对导电微球形貌的影响。实验结果表明：超声的引入可提高导电微球的单分散性,改善微球的形貌。随着pH的降低或单体配比的增加,导电聚合物在PS微球表面的负载量随之增加, 当m(EDOT)/m(PS)由0.60增加到1.25时,导电微球的平均粒径由1.76 μm增加到1.91 μm。     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.     

Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine

Evidence obtained from randomized controlled trials （RCTs） has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine （TCM） and results have shown that there is an urgent need for higher quality RCTs on TCM.     

TCM Treatment of Ankylosing Spondylitis by Tonifying the Kidney and Strengthening the Governor Vessel

Ankylosing spondylitis is a chronic and progressive disorder with inflammation mainly involving the central axis joints. It mainly affects the cervical spine and the lumbosacral area, with the pathogenesis closely related to the kidney and the Governor Vessel (GV). TCM holds that the syndrome is deficiency in origin and excess in superficiality, which is due to insufficiency of the kidney, deficiency of GV, and blocking of the channels with the invasion of exogenous evil, leading to poor circulation of qi and blood and malnutrition of the bones, muscles and joints. The TCM method of tonifying the kidney and strengthening GV to regulate circulation of qi and blood and check the arthralgia pain should be adopted, with the Kidney-Tonifying and GV Strengthening Decoction (益肾强督汤) prescribed.     

IMPROVING P-gp EXPRESSION IN HUMAN MONONUCLEAR CELLS IN VITRO TRANSFECTED BY MULTIDRUG RESISTANCE-1 mRNA

CHEMOTHERAPY playsa greatrolein the treat- ment of malignanttumors,especiallyingynecolo- gicalones.But inanticancerchemotherapy,leuko-cytopeniaisfrequentlytheprimarydose-limitingsideeffect factor.Moreover,cancersarefrequentlychemoresistantbe-causeof overexpressionof P-glycoprotein(P-gp), which isencodedby multidrugresistancegene (MDR1 ) and detectableinup to50% ofhuman cancersand renderscellsresistancetoanticancerdrugs.The safetyand potentialtherapeuticbenefitof mdr1 gene transferredto h…